VYNE Therapeutics Ownership | Who Owns VYNE Therapeutics?

VYNE Therapeutics Ownership Summary

VYNE Therapeutics is owned by 30.77% institutional investors, 4.34% insiders, and 64.90% retail investors. Nantahala capital management is the largest institutional shareholder, holding 4.68% of VYNE shares. Kennedy Micro Cap Opportunities is the top mutual fund, with 2.96% of its assets in VYNE Therapeutics shares.

VYNE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	VYNE Therapeutics	30.77%	4.34%	64.90%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Nantahala capital management	2.00M	4.68%	$1.20M
Lynx1 capital management lp	1.63M	3.81%	$973.15K
Shay capital	1.61M	3.77%	$962.12K
Anson funds management lp	1.24M	2.91%	$742.76K
Braidwell lp	916.08K	2.14%	$547.36K
Baker bros. advisors lp	851.35K	1.99%	$285.20K
Citadel advisors	514.44K	1.20%	$307.38K
Two sigma investments, lp	426.41K	1.00%	$254.78K
Acadian asset management	381.80K	0.89%	$228.00K
Geode capital management	322.71K	0.75%	$192.82K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lynx1 capital management lp	1.63M	0.15%	$973.15K
Shay capital	1.61M	0.08%	$962.12K
Rangeley capital	118.06K	0.07%	$70.54K
Anson funds management lp	1.24M	0.07%	$742.76K
Nantahala capital management	2.00M	0.04%	$1.20M
Braidwell lp	916.08K	0.02%	$547.36K
Ikarian capital	264.91K	0.01%	$158.28K
Fny investment advisers	35.00K	0.01%	$20.00K
Staley capital advisers	36.47K	0.01%	$122.18K
Corsair capital management	50.00K	0.00%	$16.75K

Top Buyers

Holder	Shares	% Assets	Change
Lynx1 capital management lp	1.63M	0.15%	1.63M
Nantahala capital management	2.00M	0.04%	1.00M
Braidwell lp	916.08K	0.02%	916.08K
Baker bros. advisors lp	851.35K	0.00%	851.35K
Citadel advisors	514.44K	-	483.92K

Top Sellers

Holder	Shares	% Assets	Change
Eventide asset management	-	-	-1.39M
Cormorant asset management, lp	-	-	-1.37M
Adage capital partners gp	-	-	-644.13K
Dafna capital management	-	-	-636.10K
Kennedy capital management	-	-	-570.74K

New Positions

Holder	Shares	% Assets	Change	Value
Lynx1 capital management lp	1.63M	0.15%	1.63M	$973.15K
Braidwell lp	916.08K	0.02%	916.08K	$547.36K
Baker bros. advisors lp	851.35K	0.00%	851.35K	$285.20K
Vanguard fiduciary trust	183.44K	-	183.44K	$109.70K
Two sigma advisers, lp	56.60K	-	56.60K	$18.96K

Sold Out

Holder	Change
Cornerstone planning group	-2.00
Ashton thomas private wealth	-19.00
Centerpoint advisors	-350.00
Royal bank of canada	-2.44K
Raymond james financial	-22.16K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	42	7.69%	13,158,549	60.87%	30	8.40%	19	-13.64%	5	-28.57%
Dec 31, 2025	19	-38.71%	3,417,865	-12.90%	7	9.49%	9	-40.00%	2	-50.00%
Sep 30, 2025	29	-29.27%	3,326,375	-51.06%	7	3.07%	15	-31.82%	2	-77.78%
Jun 30, 2025	44	15.79%	8,048,768	12.39%	18	6.70%	22	-	12	71.43%
Mar 31, 2025	38	8.57%	7,161,761	1.37%	16	6.10%	22	15.79%	7	16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Kennedy Micro Cap Opportunities	493.02K	2.96%	493.02K
Vanguard US Total Market Shares ETF	373.32K	2.45%	-
Vanguard Total Stock Mkt Idx Inv	365.33K	2.19%	-7.99K
AlphaCentric LifeSci Healthcare I	310.50K	2.11%	-134.50K
AlphaCentric Life Sciences & Hlthcare I	268.49K	1.82%	-42.02K
Alger LIfe Sciences Innovation Composite	388.07K	1.52%	388.07K
Pleiades Small Cap Equity A	149.44K	0.90%	149.44K
Vanguard Institutional Extnd Mkt Idx Tr	264.56K	0.79%	-
Fidelity Extended Market Index	205.10K	0.61%	34.48K
AZ Equity Biotechnology A-AZ EUR Acc	91.08K	0.55%	2.50K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 15, 2025	LEPORE PATRICK G	-	Buy	$43.80K
Nov 15, 2023	LEPORE PATRICK G	-	Buy	$50.78K
Mar 20, 2023	LEPORE PATRICK G	-	Buy	$49.68K
Mar 20, 2023	Harsch Mutya	Chief Legal Officer and GC	Buy	$25.00K
Nov 30, 2021	LEPORE PATRICK G	-	Buy	$12.70K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	1	-

VYNE Ownership FAQ

Who Owns VYNE Therapeutics?

VYNE Therapeutics shareholders are primarily institutional investors at 30.77%, followed by 4.34% insiders and 64.89% retail investors. The average institutional ownership in VYNE Therapeutics's industry, Biotech Stocks , is 35.75%, which VYNE Therapeutics falls below.

Who owns the most shares of VYNE Therapeutics?

VYNE Therapeutics’s largest shareholders are Nantahala capital management (2M shares, 4.68%), Lynx1 capital management lp (1.63M shares, 3.81%), and Shay capital (1.61M shares, 3.77%). Together, they hold 12.25% of VYNE Therapeutics’s total shares outstanding.

Does Blackrock own VYNE Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VYNE Therapeutics.

Who is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested?

Lynx1 capital management lp is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 1.63M VYNE Therapeutics shares, valued at 973.15K$.

Who is the top mutual fund holder of VYNE Therapeutics shares?

Kennedy Micro Cap Opportunities is the top mutual fund holder of VYNE Therapeutics shares, with 2.96% of its total shares outstanding invested in 493.02K VYNE Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools